Recombinant Human DRD5 Protein，His

Dopamine receptor D5 (DRD5) is a member of the dopamine receptor family, specifically belonging to the D1-like receptor group, which also includes DRD1. It plays a critical role in the central nervous system by mediating various physiological functions such as regulation of mood, cognition, and motor control. Research has demonstrated that alterations in DRD5 function are associated with several neuropsychiatric disorders, including schizophrenia, attention deficit hyperactivity disorder (ADHD), and substance use disorders. Given its pivotal role in neurotransmission and behavior, DRD5 has garnered significant interest as a potential target for therapeutic interventions. The study of recombinant DRD5 proteins has become increasingly important in understanding its structure-function relationship, signaling mechanisms, and interaction with other cellular proteins. By utilizing recombinant DNA technology to produce DRD5 in various expression systems, researchers can investigate its pharmacological properties, ligand-binding characteristics, and G-protein coupling efficiency. This knowledge is crucial for the development of selective drugs that can modulate DRD5 activity, offering new avenues for the treatment of dopaminergic dysregulation associated with mental health disorders. Furthermore, the characterization of DRD5 at a molecular level can enhance our understanding of dopaminergic signaling pathways and contribute to the discovery of novel biomarkers for psychological disorders. In summary, the study of DRD5 recombinant proteins not only holds promise for advancing basic neuroscience research but also offers potential therapeutic insights for various psychiatric conditions.